[
  {
    "ts": null,
    "headline": "IHF: Healthcare Dashboard For December",
    "summary": "iShares U.S. Healthcare Providers ETF presents a reasonable valuation. Learn why IHF stock stands out with cheaper healthcare stocks for December investment.",
    "url": "https://finnhub.io/api/news?id=25fd9f65de62fad6eae2cba2aa32748a230107bd178df713a24b7a9dcdb914ad",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734441311,
      "headline": "IHF: Healthcare Dashboard For December",
      "id": 132027739,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1308861166/image_1308861166.jpg?io=getty-c-w1536",
      "related": "LH",
      "source": "SeekingAlpha",
      "summary": "iShares U.S. Healthcare Providers ETF presents a reasonable valuation. Learn why IHF stock stands out with cheaper healthcare stocks for December investment.",
      "url": "https://finnhub.io/api/news?id=25fd9f65de62fad6eae2cba2aa32748a230107bd178df713a24b7a9dcdb914ad"
    }
  },
  {
    "ts": null,
    "headline": "LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal",
    "summary": "Labcorp is set to acquire select assets of MAWD Pathology Group.",
    "url": "https://finnhub.io/api/news?id=ec52a2cb4d7b23441218d9838afbee2873df428571c757c65ee65df46a0a8880",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734436980,
      "headline": "LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal",
      "id": 132026655,
      "image": "https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp is set to acquire select assets of MAWD Pathology Group.",
      "url": "https://finnhub.io/api/news?id=ec52a2cb4d7b23441218d9838afbee2873df428571c757c65ee65df46a0a8880"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new H5 bird flu molecular test to aid in the diagnosis of human infection with H5 bird flu. The test is available in the United States to physicians to order for patients suspected of infection with the H5N1 virus.*",
    "url": "https://finnhub.io/api/news?id=0dd3a6a215d0fa5fe8a1389fd76b3d28978e5d8bb330992f1ff4a908bdf11fcd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734436800,
      "headline": "Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians",
      "id": 132026656,
      "image": "https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new H5 bird flu molecular test to aid in the diagnosis of human infection with H5 bird flu. The test is available in the United States to physicians to order for patients suspected of infection with the H5N1 virus.*",
      "url": "https://finnhub.io/api/news?id=0dd3a6a215d0fa5fe8a1389fd76b3d28978e5d8bb330992f1ff4a908bdf11fcd"
    }
  }
]